Mitochondrial oxidative phosphorylation disorder

MONDO:0016387

A multisystem disorder with variable manifestations resulting from a defect in the mitochondrial oxidative phosphorylation (OXPHOS) system.

Also known as: OXPHOS disease, OXPHOS system deficiency

63 clinical trials for this condition and its sub-types, 3 tagged with Mitochondrial oxidative phosphorylation disorder itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inborn mitochondrial metabolism disorder (127)

Sub-types of Mitochondrial oxidative phosphorylation disorder

Leber hereditary optic neuropathy 18 trials
1 sub-type
- Leber optic atrophy and dystonia 0 trials
Mitochondrial DNA depletion syndrome 3 trials · 11 incl. sub-types
21 sub-types
- Mitochondrial DNA depletion syndrome, hepatocerebral form 0 trials · 4 incl. sub-types Sub-types →
- Mitochondrial DNA depletion syndrome, myopathic form 4 trials
- AFG3L2-related optic atrophy and/or spastic ataxia spectrum 0 trials Sub-types →
- Sengers syndrome 0 trials
- Mitochondrial DNA deletion syndrome with progressive myopathy 0 trials
- Mitochondrial DNA depletion syndrome 1 0 trials
- Mitochondrial DNA depletion syndrome 11 0 trials
- Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant 0 trials
- Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive 0 trials
- Mitochondrial DNA depletion syndrome 14B (cardioencephalomyopathic type) 0 trials
- Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) 0 trials
- Mitochondrial DNA depletion syndrome 16 (hepatic type) 0 trials
- Mitochondrial DNA depletion syndrome 17 0 trials
- Mitochondrial DNA depletion syndrome 18 0 trials
- Mitochondrial DNA depletion syndrome 19 0 trials
- Mitochondrial DNA depletion syndrome 20 (mngie type) 0 trials
- Mitochondrial DNA depletion syndrome 4b 0 trials
- Mitochondrial DNA depletion syndrome, encephalomyopathic form 0 trials Sub-types →
- Mitochondrial dna depletion syndrome 14A (encephalomyopathic type) 0 trials
- Mitochondrial dna depletion syndrome 16B (neuroophthalmic type) 0 trials
- Mitochondrial dna depletion syndrome 21 0 trials
Leigh syndrome 9 trials
4 sub-types
- Maternally-inherited Leigh syndrome 1 trial
- Leigh syndrome with cardiomyopathy 0 trials
- Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 0 trials
- Necrotizing encephalomyelopathy, subacute, of Leigh, adult 0 trials
Kearns-Sayre syndrome 5 trials
Maternally-inherited diabetes and deafness 5 trials
Mitochondrial respiratory chain complex deficiency 4 trials · 5 incl. sub-types
9 sub-types
Deafness, aminoglycoside-induced 4 trials
NARP syndrome 3 trials
Autosomal dominant optic atrophy, classic form 3 trials
Coenzyme Q10 deficiency 3 trials
10 sub-types
- COQ7-related distal hereditary motor neuropathy 0 trials
- Autosomal recessive ataxia due to ubiquinone deficiency 0 trials
- Coenzyme Q10 deficiency, primary, 1 0 trials
- Coenzyme Q10 deficiency, primary, 3 0 trials
- Coenzyme q10 deficiency, primary, 9 0 trials
- Deafness-encephaloneuropathy-obesity-valvulopathy syndrome 0 trials
- Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0 trials
- Familial steroid-resistant nephrotic syndrome with sensorineural deafness 0 trials
- Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome 0 trials
- Primary coenzyme Q10 deficiency 8 0 trials
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome 3 trials
Myopathy, lactic acidosis, and sideroblastic anemia 3 trials
3 sub-types
- Myopathy, lactic acidosis, and sideroblastic anemia 1 0 trials
- Myopathy, lactic acidosis, and sideroblastic anemia 2 0 trials
- Myopathy, lactic acidosis, and sideroblastic anemia 3 0 trials
Ataxia neuropathy spectrum 2 trials
2 sub-types
- Recessive mitochondrial ataxia syndrome 2 trials
- Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 1 trial Sub-types →
Pontocerebellar hypoplasia type 6 2 trials
Leber plus disease 1 trial · 2 incl. sub-types
2 sub-types
- Optic atrophy with demyelinating disease of CNS 1 trial
- Leber optic atrophy and dystonia 0 trials
Hereditary spastic paraplegia 7 1 trial
Charcot-Marie-Tooth disease recessive intermediate D 0 trials
Charcot-Marie-Tooth disease type 4K 0 trials
FASTKD2-related infantile mitochondrial encephalomyopathy 0 trials
Perrault syndrome 0 trials
7 sub-types
- Perrault syndrome 1 0 trials
- Perrault syndrome 2 0 trials
- Perrault syndrome 3 0 trials
- Perrault syndrome 4 0 trials
- Perrault syndrome 5 0 trials
- Perrault syndrome 6 0 trials
- Perrault syndrome 7 0 trials
Zellweger-like syndrome without peroxisomal anomalies 0 trials
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0 trials
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy 0 trials
1 sub-type
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 0 trials
Autosomal dominant mitochondrial myopathy with exercise intolerance 0 trials
Autosomal dominant optic atrophy and peripheral neuropathy 0 trials
Autosomal recessive optic atrophy, OPA7 type 0 trials
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0 trials
Chronic diarrhea with villous atrophy 0 trials
Combined oxidative phosphorylation deficiency 0 trials
58 sub-types
- Combined oxidative phosphorylation defect type 11 0 trials
- Combined oxidative phosphorylation defect type 13 0 trials
- Combined oxidative phosphorylation defect type 14 0 trials
- Combined oxidative phosphorylation defect type 15 0 trials
- Combined oxidative phosphorylation defect type 17 0 trials
- Combined oxidative phosphorylation defect type 2 0 trials
- Combined oxidative phosphorylation defect type 20 0 trials
- Combined oxidative phosphorylation defect type 21 0 trials
- Combined oxidative phosphorylation defect type 23 0 trials
- Combined oxidative phosphorylation defect type 24 0 trials
- Combined oxidative phosphorylation defect type 25 0 trials
- Combined oxidative phosphorylation defect type 26 0 trials
- Combined oxidative phosphorylation defect type 27 0 trials
- Combined oxidative phosphorylation defect type 30 0 trials
- Combined oxidative phosphorylation defect type 4 0 trials
- Combined oxidative phosphorylation defect type 7 0 trials
- Combined oxidative phosphorylation defect type 8 0 trials
- Combined oxidative phosphorylation defect type 9 0 trials
- Combined oxidative phosphorylation deficiency 19 0 trials
- Combined oxidative phosphorylation deficiency 28 0 trials
- Combined oxidative phosphorylation deficiency 29 0 trials
- Combined oxidative phosphorylation deficiency 32 0 trials
- Combined oxidative phosphorylation deficiency 33 0 trials
- Combined oxidative phosphorylation deficiency 34 0 trials
- Combined oxidative phosphorylation deficiency 35 0 trials
- Combined oxidative phosphorylation deficiency 36 0 trials
- Combined oxidative phosphorylation deficiency 37 0 trials
- Combined oxidative phosphorylation deficiency 38 0 trials
- Combined oxidative phosphorylation deficiency 39 0 trials
- Combined oxidative phosphorylation deficiency 40 0 trials
- Combined oxidative phosphorylation deficiency 41 0 trials
- Combined oxidative phosphorylation deficiency 42 0 trials
- Combined oxidative phosphorylation deficiency 43 0 trials
- Combined oxidative phosphorylation deficiency 44 0 trials
- Combined oxidative phosphorylation deficiency 45 0 trials
- Combined oxidative phosphorylation deficiency 46 0 trials
- Combined oxidative phosphorylation deficiency 47 0 trials
- Combined oxidative phosphorylation deficiency 48 0 trials
- Combined oxidative phosphorylation deficiency 51 0 trials
- Combined oxidative phosphorylation deficiency 52 0 trials
- Combined oxidative phosphorylation deficiency 53 0 trials
- Combined oxidative phosphorylation deficiency 54 0 trials
- Combined oxidative phosphorylation deficiency 55 0 trials
- Combined oxidative phosphorylation deficiency 56 0 trials
- Combined oxidative phosphorylation deficiency 57 0 trials
- Combined oxidative phosphorylation deficiency 58 0 trials
- Combined oxidative phosphorylation deficiency 59 0 trials
- Combined oxidative phosphorylation deficiency 60 0 trials
- Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 0 trials
- Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome 0 trials
- Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 0 trials
- Hypotonia with lactic acidemia and hyperammonemia 0 trials
- Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency 0 trials
- Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0 trials
- Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 0 trials
- Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 0 trials
- Mitochondrial proton-transporting ATP synthase complex deficiency 0 trials Sub-types →
- Severe X-linked mitochondrial encephalomyopathy 0 trials
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0 trials
Encephalopathy due to mitochondrial and peroxisomal fission defect 0 trials
2 sub-types
- Encephalopathy due to defective mitochondrial and peroxisomal fission 2 0 trials
- Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0 trials
Fatal infantile encephalocardiomyopathy 0 trials
4 sub-types
Hereditary spastic paraplegia 55 0 trials
Hereditary spastic paraplegia 77 0 trials
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome 0 trials
Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation 0 trials
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0 trials
Maternally-inherited mitochondrial dystonia 0 trials
Maternally-inherited progressive external ophthalmoplegia 0 trials
Mitochondrial DNA maintenance syndrome 0 trials
Mitochondrial non-syndromic sensorineural hearing loss 0 trials
1 sub-type
- Hearing loss, sensorineural, autosomal-mitochondrial type 0 trials
Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy 0 trials
Optic atrophy 3 0 trials
Periodic paralysis with later-onset distal motor neuropathy 0 trials
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency 0 trials
Spastic ataxia 3 0 trials
Spastic ataxia 4 0 trials
Spinocerebellar ataxia type 28 0 trials

Most studied deeper sub-types

Including sub-types (63) Tagged with Mitochondrial oxidative phosphorylation disorder (3)

Trials to join now! 25 Not yet recruiting 6 Not yet finished but already full! 16 Completed 15 Terminated 1

Mitochondrial oxidative phosphorylation disorder

Where it sits in the disease tree

Most studied deeper sub-types

New eye injection aims to slow genetic blindness

Last chance access: vatiquinone for mitochondrial disease patients

Could stem cells slow MSA? new trial tests safety and effects

Could vitamin B3 save sight in rare optic nerve disease?

Could a common drug help kids with rare leigh syndrome?

Balance-Restoring implant trial offers hope for chronic dizziness sufferers

Desperate hope: gene therapy tested in one patient with rare blindness

Gene therapy aims to restore sight in rare blindness condition

Experimental treatment aims to boost mitochondrial DNA in rare disease

New study tests workplace coaching to keep Parkinson's patients on the job

New program aims to ease burden on families of kids with rare diseases

Scientists track rare liver diseases in kids to unlock clues

Massive genetic study aims to unlock secrets of rare metabolic diseases

MRI scans could unlock secrets of rare muscle disease

Massive gene hunt launched for mysterious mitochondrial diseases

Tiny power plants in cells may weaken bones, new study hints